Completed
Creatine Supplementation on Kidney Function in Resistance-trained Individuals
What is being tested
creatine
+ placebo
Dietary Supplement
Who is being recruted
From 18 to 30 Years
+6 Eligibility Criteria
How is the trial designed
Placebo-Controlled
Interventional
Study Start: July 2011
Summary
Principal SponsorUniversity of Sao Paulo
Last updated: March 25, 2013
Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 2011
Actual date on which the first participant was enrolled.There is a claim that creatine supplementation might affect kidney function, especially in those consuming a high-protein diet. The aim of this study was to investigate the effects of creatine supplementation on kidney function in resistance-trained individuals ingesting a high-protein diet.
Principal SponsorUniversity of Sao Paulo
Last updated: March 25, 2013
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
46 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Male
Biological sex of participants that are eligible to enroll.From 18 to 30 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
2 inclusion criteria required to participate
consumption of a high-protein diet ( >= 1.2 g/Kg/d)
participation in recreational resistance training
4 exclusion criteria prevent from participating
chronic kidney disease
use of anabolic steroids
use of creatine supplements in the past 6 months
vegetarian diet
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
Experimental20 g/d for 5 d followed by 5 g/d throughout the trial
Group II
Placebo20 g/d for 5 d followed by 5 g/d throughout the trial
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center